Cargando…

Circular RNA SMARCA5 may serve as a tumor suppressor in non‐small cell lung cancer

BACKGROUND: This study aimed to investigate the correlation of circular RNA SMARCA5 (circ‐SMARCA5) expression with clinicopathological characteristics and survival profiles, furthermore, to explore the function of circ‐SMARCA5 on regulating cell proliferation and chemotherapy sensitivity in non‐smal...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tong, Suiju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246390/ https://www.ncbi.nlm.nih.gov/pubmed/31944395 http://dx.doi.org/10.1002/jcla.23195

Ejemplares similares

CircSMARCA5: A key circular RNA in various human diseases
por: Zhu, Yi, et al.
Publicado: (2022)

Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
por: Chao, Fan, et al.
Publicado: (2021)

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
por: Ramos, Pilar, et al.
Publicado: (2014)

Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axis
por: Wang, Yaqiu, et al.
Publicado: (2019)

MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4
por: Schramedei, K, et al.
Publicado: (2011)

Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma
por: Lu, Qi, et al.
Publicado: (2019)

Circular RNA SMARCA5 Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer by miR-19b-3p/HOXA9 Axis [Retraction]
Publicado: (2021)

Circular RNA cSMARCA5 regulates the progression of cervical cancer by acting as a microRNA-432 sponge
por: Huang, Ping, et al.
Publicado: (2020)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Circular RNA SMARCA5 inhibits gastric cancer progression through targeting the miR-346/ FBXL2 axis
por: Li, Quanying, et al.
Publicado: (2019)

Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer
por: Liang, Xiyue, et al.
Publicado: (2023)

Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis
por: Wang, Guangxin, et al.
Publicado: (2023)

Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer
por: Huang, Mei, et al.
Publicado: (2017)

Circular RNA SMARCA5 is overexpressed and promotes cell proliferation, migration as well as invasion while inhibits cell apoptosis in bladder cancer
por: Tan, Yiao, et al.
Publicado: (2019)

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

Glypican-5 is a tumor suppressor in non-small cell lung cancer cells
por: Guo, Lixia, et al.
Publicado: (2016)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

Circular RNA hsa_circ_0014243 may serve as a diagnostic biomarker for essential hypertension
por: Zheng, Shuying, et al.
Publicado: (2019)

SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer
por: Mehta, Anurag, et al.
Publicado: (2021)

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
por: Xue, Yibo, et al.
Publicado: (2019)

The Circular RNA Landscape of Non-Small Cell Lung Cancer Cells
por: Van Der Steen, Nele, et al.
Publicado: (2020)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

Circular non‐coding RNA circ_0072088 serves as a ceRNA, targeting the miR‐1225‐5p/WT1 axis to regulate non‐small cell lung cancer cell malignant behavior
por: Zhu, Xiaofang, et al.
Publicado: (2023)

DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma
por: Fang, Wentong, et al.
Publicado: (2020)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Circularized synthetic oligodeoxynucleotides serve as promoterless RNA polymerase III templates for small RNA generation in human cells
por: Seidl, Christine I., et al.
Publicado: (2013)

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
por: Lin, Yun-Tzu, et al.
Publicado: (2023)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer
por: Xue, Changning, et al.
Publicado: (2022)

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
por: Naito, Tomoyuki, et al.
Publicado: (2019)

Circular RNA, circular RARS, promotes aerobic glycolysis of non‐small‐cell lung cancer by binding with LDHA
por: Li, Haoran, et al.
Publicado: (2023)

CircRNA May Not Be “Circular”
por: Sun, Handong, et al.
Publicado: (2021)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
por: Tagal, Vural, et al.
Publicado: (2017)

SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target
por: Chen, Guanghui, et al.
Publicado: (2018)

Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
por: Zhang, Chuantao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k04tgudtk0k4k4gmhi7g0lsgbf